3-Chloro-4-morpholino-1,2,5-thiadiazole,
30165-96-9,
4-(4-Chloro-1,2,5-thiadiazol-3-yl)morpholine,
4-Chloro-3-morpholino-1,2,5-thiadiazole,
UNII-M15N21L9HT,
3-Chloro-4-morpholin-4-yl-1,2,5-thiadiazole,
4-(4-Chloro-[1,2,5]thiadiazol-3-yl)-morpholine,
Morpholine, 4-(4-chloro-1,2,5-thiadiazol-3-yl)-,
M15N21L9HT,
Timolol Impurity,
EINECS 250-077-1,
ZERO/001413,
PubChem20788,
ACMC-1COEF,
AI3-62392,
AC1L3T4P,
TimTec1_001315,
KSC496Q0D,
SCHEMBL2207978,
Jsp005699,
CTK3J6801,
LAUCCQWGVCJGFT-UHFFFAOYSA-,
DTXSID50184248,
LAUCCQWGVCJGFT-UHFFFAOYSA-N,
HMS1537L17,
ZINC131479,
ALBB-006901,
EBD14467,
KS-00000KV2,
ANW-26789,
BBL004255,
MFCD00274160,
SBB000450,
STK299984,
AKOS000266398,
1,2,5-Thiadiazole, morpholine deriv.,
AC-8487,
AN-7973,
MCULE-9560440423,
RTR-050415,
NCGC00174560-01,
AJ-12106,
AK-25736,
BAS 00219065,
BC682511,
CJ-00987,
SC-65332,
ST016621,
TS-02943,
U755,
ZB004569,
3-Morpholino-4-chloro-1,2,5-thiadiazole,
AB0019443,
DB-047719,
TR-050415,
BB 0242859,
EU-0052261,
FT-0638908,
ST24042045,
W-6772,
A820231,
SR-01000526365,
4-(4-chloranyl-1,2,5-thiadiazol-3-yl)morpholine,
4-(4-Chloro-1,2,5-thiadiazol-3-yl)morpholine #,
I14-0718,
SR-01000526365-1,
W-106954,
3-Chloro-4-morpholin-4-yl-1,2,5-thiadiazole, 98%,
BRD-K04184944-001-01-0,
InChI=1/C6H8ClN3OS/c7-5-6(9-12-8-5)10-1-3-11-4-2-10/h1-4H2,
Timolol Related Compound F, United States Pharmacopeia (USP) Reference Standard,
3-Chloro-4-N-morpholine-1,2,5-thiadiazole; 3-Morpholino-4-chloro-1,2,5-thiadiazole; 4-(4-Chloro-1,2,5-thiadiazol-3-yl)morpholine,
C6H8ClN3OS,
C6-H8-Cl-N3-O-S,
ACN-S005406,
CID121645,
(5R)-5-methyl-2-piperazinone hydrochloride,
C2189,